Search Results - "Lad, Sangeeta"

Comparative evaluation of 177Lu-DOTATATE and 90Y-DOTATATE in SSTR II overexpressing Xenograft models for treatment of variable volume neuroendocrine tumours by Tawate, Megha, Sahu, Sudeep, Chakraborty, Avik, Lad, Sangeeta, Gaikwad, Sujay, Mitra, Arpit, Upadhye, Trupti, Menon, Sreeja, Damle, Archana, Banerjee, Sharmila

Get full text

P-302 - Comparative evaluation of 177Lu-DOTATATE and 90Y-DOTATATE in SSTR II overexpressing Xenograft models for treatment of variable volume neuroendocrine tumours by Tawate, Megha, Sahu, Sudeep, Chakraborty, Avik, Lad, Sangeeta, Gaikwad, Sujay, Mitra, Arpit, Upadhye, Trupti, Menon, Sreeja, Damle, Archana, Banerjee, Sharmila

Get full text

Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3 by Tawate, Megha, Mitra, Arpit, Chakraborty, Avik, Lad, Sangeeta, Gaikwad, Sujay, Sahu, Sudeep, Rakshit, Sutapa, Menon, Sreeja, Ray, Mukti Kant, Damle, Archana, Banerjee, Sharmila

Get full text

P-297 - Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model by Sahu, Sudeep, Tawate, Megha, Lad, Sangeeta, Chakraborty, Avik, Mitra, Arpit, Rakshit, Sutapa, Upadhye, Trupti, Wanage, Gaurav, Ray, Mukti Kant, Damle, Archana, Kulkarni, Savita, Baghel, Nawab

Get full text

Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model by Sahu, Sudeep, Tawate, Megha, Lad, Sangeeta, Chakraborty, Avik, Mitra, Arpit, Rakshit, Sutapa, Upadhye, Trupti, Wanage, Gaurav, Ray, Mukti Kant, Damle, Archana, Kulkarni, Savita, Baghel, Nawab

Get full text

Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation by Sahu, Sudeep, Tawate, Megha, Lad, Sangeeta, Chakraborty, Avik, Mitra, Arpit, Rakshit, Sutapa, Upadhye, Trupti, Wanage, Gaurav, Ray, Mukti Kant, Damle, Archana, Kulkarni, Savita, Baghel, Nawab

Get full text

In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor by Tawate, Megha, Chakraborty, Avik, Mitra, Arpit, Lad, Sangeeta, Gaikwad, Sujay, Sahu, Sudeep, Upadhye, Trupti, Rakshit, Sutapa, Menon, Sreeja, Ray, Mukti Kant, Damle, Archana, Banerjee, Sharmila

Get full text

P-176 - Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3 by Tawate, Megha, Mitra, Arpit, Chakraborty, Avik, Lad, Sangeeta, Gaikwad, Sujay, Sahu, Sudeep, Rakshit, Sutapa, Menon, Sreeja, Ray, Mukti Kant, Damle, Archana, Banerjee, Sharmila

Get full text

P-301 - In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor by Tawate, Megha, Chakraborty, Avik, Mitra, Arpit, Lad, Sangeeta, Gaikwad, Sujay, Sahu, Sudeep, Upadhye, Trupti, Rakshit, Sutapa, Menon, Sreeja, Ray, Mukti Kant, Damle, Archana, Banerjee, Sharmila

Get full text

P-298 - Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation by Sahu, Sudeep, Tawate, Megha, Lad, Sangeeta, Chakraborty, Avik, Mitra, Arpit, Rakshit, Sutapa, Upadhye, Trupti, Wanage, Gaurav, Ray, Mukti Kant, Damle, Archana, Kulkarni, Savita, Baghel, Nawab

Get full text